Global Viral Vector and Plasmid DNA Manufacturing Market Analysis, Growth, Trends & Forecast 2018-2023 - ResearchAndMarkets.com

DUBLIN--()--The "Global Viral Vector and Plasmid DNA Manufacturing Market - Segmented by Product Type, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

Viral vectors and plasmid DNA are products of gene therapy, which are used for the treatment of a large number of diseases. The advantages of gene vaccines and gene therapy over conventional vaccines and therapies include the ability to induce a wider range of immune response types. The global viral vector and plasmid DNA manufacturing market is expected to register a CAGR of 19.5% during the forecast period 2018-2023.

Technological advancements to mitigate challenges posed by conventional methods of vector production and growing number of gene therapy candidates, coupled with their rapid progression through the various phases of clinical developments, are some of the other factors contributing to the growth of the market.

The extent of the potential of gene therapy to combat genetic disorders that are beyond conventional cure is unparalleled. The support afforded by patient organizations to gene therapy is significant, and the field is indebted to the thousands of patient volunteers, who have taken part in clinical trials over decades. But, the actual problem is whether gene therapies are accessible and affordable to the patients or not. To date, companies have sought extraordinarily high prices for gene therapy products that reach the market. The readiness and ability of healthcare systems to afford these products will determine whether or not the potential of gene therapies will be fully realized.

Companies Mentioned

  • Fujifilm Diosynth Biotechnologies
  • Sanofi S.A.K Therapeutics
  • Uniqure
  • Massbiologics
  • Finvector
  • Brammer Bio
  • Cell And Gene Therapy Catapult
  • Cobra Biologics

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/kzw8f5/global_viral?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics